# Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma)

> **NCT03230201** · NA · UNKNOWN · sponsor: **Peking University First Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Recurrence
- Metastasis
- Upper Tract Urothelial Carcinoma
- Lymph Node Dissection

## Interventions

- **PROCEDURE:** Lymph node dissection

## Key facts

- **NCT ID:** NCT03230201
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-01
- **Primary completion:** 2021-01-01
- **Final completion:** 2021-01-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2017-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03230201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03230201, "Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03230201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*